Skip to main content

SAB Biotherapeutics, Inc.

SABS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001833214

No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.

Other share classesSABSW

13F holders, Q1 2026

Institutional positions in SAB Biotherapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
76
+29 vs. Q4 2025
Shares held
69.2M
+34.7M (+100.6%) vs. Q4 2025
Total value
$265.0M
+$136.0M (+105.4%) vs. Q4 2025
New holders
34
24 more added
Sold out
5
7 more reduced

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 76 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 1 institutionQ4 2021: 34 institutionsQ1 2022: 27 institutionsQ2 2022: 37 institutionsQ3 2022: 40 institutionsQ4 2022: 38 institutionsQ1 2023: 39 institutionsQ2 2023: 38 institutionsQ3 2023: 34 institutionsQ4 2023: 42 institutionsQ1 2024: 24 institutionsQ2 2024: 22 institutionsQ3 2024: 25 institutionsQ4 2024: 25 institutionsQ1 2025: 26 institutionsQ2 2025: 25 institutionsQ3 2025: 34 institutionsQ4 2025: 48 institutionsQ1 2026: 76 institutionsQ2 2026: 87 institutions
Value heldQ1 2026: $265.0M
Q1 2021: $0Q2 2021: $0Q3 2021: $605.0KQ4 2021: $25.4MQ1 2022: $6.71MQ2 2022: $4.45MQ3 2022: $2.32MQ4 2022: $2.42MQ1 2023: $1.71MQ2 2023: $3.28MQ3 2023: $2.41MQ4 2023: $24.5MQ1 2024: $15.2MQ2 2024: $9.69MQ3 2024: $8.48MQ4 2024: $10.1MQ1 2025: $2.99MQ2 2025: $3.37MQ3 2025: $56.3MQ4 2025: $135.9MQ1 2026: $265.0MQ2 2026: $266.8M
Institutions holding SABS and their total value by quarter
QuarterHoldersValue
Q2 202687$266.8M
Q1 202676$265.0M
Q4 202548$135.9M
Q3 202534$56.3M
Q2 202525$3.37M
Q1 202526$2.99M
Q4 202425$10.1M
Q3 202425$8.48M
Q2 202422$9.69M
Q1 202424$15.2M
Q4 202342$24.5M
Q3 202334$2.41M
Q2 202338$3.28M
Q1 202339$1.71M
Q4 202238$2.42M
Q3 202240$2.32M
Q2 202237$4.45M
Q1 202227$6.71M
Q4 202134$25.4M
Q3 20211$605.0K
Q2 20210$0
Q1 20210$0

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q4 2025.

Institutions holding SABS in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada1$00.00%+1New
Harbour Investments, Inc.50$1920.00%00.0%Unchanged
JPMorgan Chase & Co87$3290.00%−1,903−95.6%Reduced
Caitong International Asset Management Co., Ltd161$6170.00%+161New
Gs Investments, Inc.200$7660.00%00.0%Unchanged
MAI Capital Management217$8320.00%00.0%Unchanged
Barclays PLC496$1.90K0.00%+496New
BNP Paribas Arbitrage, SA889$3.40K0.00%+889New
Tower Research Capital LLC (TRC)3,269$12.5K0.00%+3,269New
Simplex Trading, LLC4,713$18.1K0.00%+4,713New
Plante Moran Financial Advisors, LLC5,925$22.7K0.00%+5,925New
The PNC Financial Services Group, Inc.7,700$29.5K0.00%+7,700New
Advisor Group Holdings, Inc.7,775$29.8K0.00%+2,751+54.8%Added
State of Wyoming7,899$30.3K0.00%−1,072−11.9%Reduced
Scientech Research LLC10,816$41.4K0.03%+10,816New
Vanguard Global Advisers, LLC11,852$45.4K0.00%+11,852New
Morgan Stanley11,911$45.6K0.00%+7,649+179.5%Added
Miller Capital Partners, Inc.12,870$49.3K0.02%+12,870New
Colony Group, LLC14,036$53.8K0.00%−5,165−26.9%Reduced
Catalyst Funds Management Pty Ltd15,100$57.8K0.01%+15,100New
Hudson Bay Capital Management LP16,100$61.7K0.00%+16,100New
Diametric Capital, LP16,292$62.4K0.02%+16,292New
First PREMIER Bank18,986$73.0K0.02%00.0%Unchanged
Qube Research & Technologies Ltd24,098$92.3K0.00%−7,049−22.6%Reduced
Omers Administration Corp29,700$113.8K0.00%−12,300−29.3%Reduced
Prelude Capital Management, LLC34,124$130.7K0.01%+34,124New
Quadrature Capital Ltd35,264$135.1K0.00%+35,264New
Citigroup Inc36,805$141.0K0.00%+6,831+22.8%Added
American Century Companies Inc37,455$143.5K0.00%+37,455New
Virtu Financial LLC37,943$145.0K0.01%+37,943New
Commonwealth Equity Services, LLC46,455$177.9K0.00%+46,455New
Fifth Lane Capital, LP46,500$178.1K0.22%+31,500+210.0%Added
UBS Group AG46,623$178.6K0.00%+39,225+530.2%Added
Stonepine Capital Management, LLC50,000$191.5K0.17%+50,000New
Pathstone Holdings, LLC50,650$194.0K0.00%00.0%Unchanged
Bank of America Corp55,697$213.3K0.00%+45,084+424.8%Added
Northern Trust Corp57,426$219.9K0.00%+41,014+249.9%Added
Brevan Howard Capital Management LP59,161$226.6K0.00%+59,161New
Kestra Advisory Services, LLC61,741$236.5K0.00%+50,191+434.6%Added
Persistent Asset Partners Ltd69,732$267.1K0.10%+49,942+252.4%Added
State Street Corp74,231$284.3K0.00%+61,109+465.7%Added
Seven Fleet Capital Management LP100,000$383.0K0.12%+100,000New
Goldman Sachs Group Inc113,940$436.4K0.00%+62,592+121.9%Added
Two Sigma Investments, LP181,185$693.9K0.00%+181,185New
Simplify Asset Management Inc.187,230$717.1K0.01%−20,997−10.1%Reduced
Vanguard Fiduciary Trust Co197,619$756.9K0.00%+197,619New
Seven Grand Managers, LLC275,000$1.05M0.07%+275,000New
BlackRock, Inc.301,326$1.15M0.00%+284,087+1,647.9%Added
Geode Capital Management, LLC302,036$1.16M0.00%+182,519+152.7%Added
HB Wealth Management, LLC307,500$1.18M0.01%00.0%Unchanged
StemPoint Capital LP375,000$1.44M0.28%+228,442+155.9%Added
AWM Investment Company, Inc.400,000$1.53M0.17%+200,000+100.0%Added
DV Trading LLC400,000$1.53M0.14%+400,000New
Marshall Wace, LLP463,925$1.78M0.00%+227,465+96.2%Added
Monashee Investment Management LLC500,000$1.92M1.04%+500,000New
Affinity Asset Advisors, LLC575,000$2.20M0.13%+575,000New
ExodusPoint Capital Management, LP768,627$2.94M0.03%+682,514+792.6%Added
Blackstone Group Inc.860,170$3.29M0.01%−1,283,415−59.9%Reduced
Jefferies Financial Group Inc.903,094$3.46M0.04%+322,766+55.6%Added
Propel Bio Management, LLC1,012,790$3.89M2.45%+359,909+55.1%Added
Soleus Capital Management, L.P.1,050,000$4.02M0.16%+1,050,000New
Ensign Peak Advisors, Inc1,375,610$5.27M0.01%+1,375,610New
Ameriprise Financial Inc1,476,106$5.65M0.00%+1,192,461+420.4%Added
Boothbay Fund Management, LLC1,481,660$5.67M0.13%+1,481,660New
Sessa Capital IM, L.P.2,198,457$8.42M0.16%00.0%Unchanged
Spruce Street Capital LP2,198,502$8.42M2.02%00.0%Unchanged
Vanguard Capital Management LLC2,493,737$9.55M0.00%+2,493,737New
Woodline Partners LP2,851,791$10.9M0.04%+9100.0%Added
Millennium Management LLC3,032,697$11.6M0.01%+2,708,607+835.8%Added
Adage Capital Partners GP, L.L.C.3,405,553$13.0M0.02%+3,405,553New
Balyasny Asset Management LLC3,760,439$14.4M0.03%+3,285,000+690.9%Added
Ra Capital Management, L.P.4,401,500$16.9M0.18%00.0%Unchanged
Commodore Capital LP4,401,500$16.9M0.98%00.0%Unchanged
Perceptive Advisors LLC6,431,743$24.6M0.49%+5,628,533+700.8%Added
Caligan Partners LP7,967,207$30.5M2.16%+7,967,207New
Vivo Capital, LLC11,420,000$43.7M3.64%00.0%Unchanged
Verition Fund Management LLC0$00.00%−26,867−100.0%Sold out
ADAR1 Capital Management, LLC0$00.00%−26,344−100.0%Sold out
Citadel Advisors LLC0$00.00%−17,650−100.0%Sold out
Caxton Corp0$00.00%−10,527−100.0%Sold out
SBI Securities Co., Ltd.0$00.00%−50−100.0%Sold out
Vanguard Group Inc––––Not filed